Sustained Release Excipients Market Size & Share, By Route Of Administration (Oral, Transdermal), Technology (Transdermal, Implants), Product (Gelatin, Sugars), Regional Forecast, Industry Players, Growth Statistics Report 2023-2030

Market Outlook:

Sustained Release Excipients Market size surpassed USD 1.19 Billion in 2022 and is poised to reach USD 2.59 Billion, growing at over 9.66% CAGR between 2023 and 2030. This market has gained substantial traction due to the increasing demand for drug delivery systems with controlled release properties. Sustained release excipients play a crucial role in formulating such drug delivery systems, ensuring the controlled and prolonged release of drugs, which enhances patient compliance and therapeutic efficacy. With advancements in pharmaceutical research and development, there has been a surge in the adoption of sustained release excipients across various therapeutic areas.

• Base Year Value (2022): USD 1.19 Billion
• CAGR (2023-2030): 9.66%
• Forecast Year Value (2030): USD 2.59 Billion
• Historical Data Period: 2018-2021
• Largest Region: North America
• Forecast Period: 2023-2030

Market Dynamics:

Growth Drivers & Opportunities:

1. Rising Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases such as cardiovascular disorders, diabetes, and neurological conditions has resulted in the growing demand for sustained release drug delivery systems. Sustained release excipients enable controlled drug release, minimizing the frequency of drug administration and enhancing patient convenience.

2. Growing Geriatric Population: The population of elderly individuals is on the rise globally, leading to an increased demand for sustained release drug products. Geriatric patients often have multiple chronic conditions and difficulties in adhering to complex medication regimens. Sustained release excipients provide a solution by facilitating long-term drug release, reducing the frequency of medication administration, and improving patient compliance.

3. Technological Advancements: Continuous advancements in drug delivery technologies have significantly contributed to the growth of the sustained release excipients market. Innovations such as microencapsulation, nanotechnology, and liposomal drug delivery systems have expanded the scope of sustained release excipients, driving market growth.

 

Industry Restraints & Challenges:

Report Scope

Report Coverage	Details
Segments Covered	Product, Technology, Route Of Administration, Region
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	BASF, International Flavors & Fragrances, Ashland Global: Evonik Industries AG, Croda International Plc, Gattefoss, Merck KGaA.

1. Stringent Regulatory Requirements: The regulatory environment for sustained release excipients is complex and stringent due to safety concerns and the need for quality assurance. Compliance with regulatory standards can pose a challenge for manufacturers, limiting the entry of new players into the market.

2. High Development Costs: The development and commercialization of sustained release drug products require substantial financial investments. The extensive research and development efforts, along with the associated clinical trials, can increase the overall cost of drug development. This acts as a barrier, particularly for small and medium-sized pharmaceutical companies, restraining market growth to some extent.

3. Potential Side Effects and Allergies: Certain sustained release excipients may present side effects or allergic reactions in some individuals. As patient safety remains a priority, careful consideration and evaluation are essential while selecting excipients for formulating sustained release drug products.

Despite these challenges, the sustained release excipients market is poised for significant growth in the coming years, driven by the increasing demand for controlled drug release systems and advancements in drug delivery technologies. Manufacturers who prioritize research and development, as well as regulatory compliance, have immense opportunities to tap into this expanding market.

Regional Forecast:

North America

North America is expected to dominate the sustained release excipients market during the forecast period. The region has witnessed significant growth in the pharmaceutical industry, with a high demand for novel drug delivery systems. The presence of well-established market players and increasing investments in research and development activities contribute to the region's market growth. Moreover, favorable government initiatives aimed at promoting advanced drug delivery technologies further propel the market expansion in North America.

Asia Pacific

Asia Pacific is anticipated to experience substantial growth in the sustained release excipients market. This is primarily attributed to the increasing population, improved healthcare infrastructure, and rising pharmaceutical manufacturing activities in countries like India and China. Additionally, the region is witnessing a surge in contract manufacturing organizations (CMOs), fostering the market growth. Furthermore, the presence of a large pool of raw material suppliers and low production costs contribute to the market's development in the Asia Pacific region.

Europe

Europe is expected to exhibit significant growth in the sustained release excipients market. The region is characterized by a well-established pharmaceutical industry, with a high demand for innovative drug delivery systems. Increasing research and development activities, coupled with the presence of key market players, drive the market's growth in Europe. Moreover, the rising geriatric population and the prevalence of chronic diseases further contribute to the market expansion in the region.

Segmentation Analysis:

The sustained release excipients market can be segmented based on type, formulation, and application. One notable sub-segment from each segment is discussed below.

Segment: Type

Sub-segment: Polymers

Polymers are a commonly used type of sustained release excipient. They offer various advantages, including controlled drug release, improved bioavailability, enhanced stability, and customized drug release rates. Polymers such as hydrogels, biodegradable polymers, and pH-sensitive polymers enable precise control and sustained release of drugs over an extended period. Furthermore, the increasing demand for biodegradable polymers in sustained release formulations promotes the growth of the polymer sub-segment within the sustained release excipients market.

Segment: Formulation

Sub-segment: Injectable

The injectable formulation sub-segment is gaining significant traction in the sustained release excipients market. Injectable sustained release formulations offer numerous advantages, such as sustained drug release, reduced dosing frequency, and improved patient compliance. They are widely utilized for the delivery of peptides, proteins, and other therapeutic agents. The growing demand for long-acting injectable formulations, especially for chronic diseases, fuels the adoption of injectable sustained release excipients, driving the growth of this sub-segment.

Segment: Application

Sub-segment: Cardiovascular Diseases

Sustained release excipients find extensive application in the treatment of cardiovascular diseases. By providing controlled drug release, sustained release excipients help in maintaining optimal drug concentrations in the bloodstream, thereby enhancing treatment efficacy and reducing the frequency of administration. These excipients are utilized in the formulation of sustained release drugs for conditions such as hypertension, angina, and heart failure. The increasing prevalence of cardiovascular diseases globally drives the demand for sustained release excipients in this application segment.

Competitive Landscape:

The sustained release excipients market is highly competitive, with several prominent players operating worldwide. Some of the key market players include:

1. DowDuPont Inc.

2. Ashland Global Holdings Inc.

3. Evonik Industries AG

4. BASF SE

5. Colorcon Inc.

6. Lubrizol Corporation

7. FMC Corporation

8. Roquette Freres

9. Shin-Etsu Chemical Co., Ltd.

10. Croda International Plc.

These companies focus on strategic partnerships, mergers and acquisitions, and product launches to strengthen their market position. Additionally, research and development activities aimed at developing innovative sustained release excipients are undertaken to gain a competitive edge. The sustained release excipients market is characterized by intense competition and technological advancements, driving the market players to constantly innovate and expand their product portfolios.